News

Healthcare, Life Sciences

All news
Stereotaxis acquiert Robocath : une innovation française de la robotique cardiaque passe sous pavillon américain
06/05/2026
Mergers & Acquisitions

Stereotaxis acquires Robocath: a French cardiac robotics innovation moves under U.S. ownership

In April 2026, Stereotaxis, listed on the NYSE, announced the acquisition of Rouen-based start-up Robocath for up to $45 million. This transatlantic transaction highlights both the maturity of the French medtech ecosystem and the financing challenges faced by European deeptech companies in scaling up. Insights and analysis by the experts at AURIS Finance, an M&A […]
NeuroClues lève 10 millions d’euros et accélère l’industrialisation de sa solution
27/04/2026
Funding & Fundraising

NeuroClues raises €10 million to accelerate the industrialization of its solution

The momentum of French MedTech companies continues with NeuroClues’ latest fundraising round. The start-up, which specializes in ocular biomarkers for neurological diagnosis, has announced a new €10 million financing round. This funding transaction will enable NeuroClues to enter a key industrialization phase built around artificial intelligence and accelerate its international expansion. Insights and analysis by […]
Infirmière réalisant une piqure d'insuline, pour illustrer la levée de fonds de DiappyMed aux côtés de Ventech & Sanofi
02/04/2026
Funding & Fundraising

Fundraising: DiappyMed accelerates with Ventech and enters into a strategic partnership with Sanofi

A new milestone for the Montpellier-based MedTech company. DiappyMed, a specialist in digital therapies for diabetes, is scaling up its operations. The start-up has successfully completed a €5 million seed funding round led by Ventech and has also announced a strategic partnership with Sanofi. An analysis by the experts at AURIS Finance, a leading M&A […]
biotechs biotech
24/03/2026
Mergers & Acquisitions, Financial News

Biotech funds back in search of performance

After years marked by high capital costs and a pronounced risk aversion among investors, a new cycle is emerging for biotech companies, as evidenced by the resurgence of merger and acquisition activity. Insights and analysis by the experts at AURIS Finance, a corporate finance advisory firm specialising in mergers and acquisitions. In 2025, the Nasdaq […]
Jeune soignant aidant une femme âgée à marcher, représentant le rachat de Nordic Medcom par Physidia
16/03/2026

Physidia Acquires Nordic Medcom

The French home dialysis specialist, Physidia, has announced the acquisition of Nordic Medcom, its long‑standing partner and distributor in the Nordic countries (Finland, Sweden, Norway, Denmark). This transaction marks a significant milestone in Physidia’s international development and opens a new phase focused on expanding access to home hemodialysis therapy across Europe, responding to global trends […]
Un praticien et une patiente, représentant le rachat par le FI Extens de deux groupes dans l'orthodontie
13/03/2026
Mergers & Acquisitions

Extens, a healthcare-focused investment fund, acquires two leaders in orthodontic software

Software solutions Orthalis and Dentalsoft are now under the ownership of Extens. This transaction leads to the creation of SignalSoft Développement, a new player in orthodontic software. The experts at AURIS Finance, a financial advisory firm specializing in mergers and acquisitions, analyze this new market move. Under the leadership of Extens, Orthalis and Dentalsoft are […]
See More